Figure 4.
Remdesivir global clinical trials. Shown are the locations of the clinical study sites for the ongoing clinical studies of remdesivir for SARS-CoV-2/COVID-19. Number of sites participating for each respective study, if no specific information was given, shown are the countries participating (e.g., ISRCTN83971151). Listed are the number of sites participating for each respective study, if no detailed information was provided; shown are the number of countries participating. NCT04302766 is an expanded access trial with no specific sites listed in the registration. Figure created with R,91 utilizing the packages rnaturalearth,92 sf,93 and ggplot2.94